Our portable punch biopsy kit reduces NHS waiting times from 6-9 months to days, at a fraction of the cost
CAnswer BioSolutions is developing advanced cancer diagnostic solutions that combine innovative biopsy technology with AI-assisted analysis to transform how cancer is detected and diagnosed.
Our mission is to make cancer diagnostics more accessible, affordable, and efficient, helping to save lives through earlier detection.
Months current NHS biopsy waiting time
Improved survival with early diagnosis
Cost of conventional hospital biopsy
Cost of our portable biopsy solution
Transforming cancer diagnostics through portable technology and AI assistance, making detection faster, more affordable, and less traumatic for patients.
Our innovative portable punch biopsy kit enables surgeons to perform cancer diagnostics outside of traditional hospital settings, dramatically reducing waiting times and costs.
Our AI-assisted diagnostic platform enables pathologists to upload images of slides for computational analysis, making the diagnostic process faster and more accurate.
Innovative technology designed to transform cancer diagnostics, from sample collection to analysis.
Our gentle anaesthesia delivery system reduces psychological distress associated with visible needles and multiple injections, making procedures more comfortable.
Our room temperature sample preservation technology eliminates specialised transport requirements, allowing samples to be transported via standard courier services
Our AI-assisted platform allows pathologists to analyse slide images computationally, potentially improving diagnostic efficiency and accuracy
Quick and easily deployable dual-purpose marine-creature-derived hemostatic tape, designed for both microvascular anastomosis support and open-wound management.
Our innovative approach to cancer diagnostics is designed to have a significant impact on healthcare systems and patient outcomes.
Our novel biopsy and diagnosis solutions can reduce expenditures by up 90%, potentially saving the NHS an estimated £530 million annually while improving patient outcomes.
Efficiency & Cost Savings
Reducing waiting times and infrastructure needs
With approximately 156,000 annual skin cancer patients in the UK facing 6-9 month waiting times, our solution aims to dramatically accelerate diagnosis and improve survival rates.
Early Detection Saves Lives
Up to 90% improved survival rates
A multidisciplinary team of experts dedicated to transforming cancer diagnostics.
Head,neck trauma and cancer surgeon, with a knack for constant innovation
AI Scientist and Technology Lead.
Microbiologist and Logistics Lead.
Finances, and product development leader
Dr. Liliyana Kalinova, legal counsel and team lawyer, PhD, LLM, LLB.
ESBF Champions of Champion 2025! Best Technical Idea 🏆, sponsored by E-Careers, and Royal Academy of Engineering, London.
Runner-Up 🏆, Converge KickStart Challenge 2025.
Finalists in Scottish EDGE Young 2025!
Finalists in 1) Rising Star & 2) Start-up Business of the Year at the Northern Star Business Awards 2026, Sponsered by Aberdeen & Grampian Chamber of Commerce and Brodies LLP.
10th May 2025- Best Pitch award, Converge Kickstart National Training, Heriot-Watt University, Edinburgh
June, 2025- CAnswer BioSolutions Ltd. hosted 2 Post Graduate Interns from University of Aberdeen, under their Work-based Learning Programme. Ms. Parvathi Vismithaa, and Ms. Bushra Yahya are working on an internal market research project.
08th June 2025- University of Aberdeen, and ABVenture's Take Off Student Accelerator Showcase event-
1) 1st prize, Stage Gate Business Model Canvass presentation
2) 3rd prize, Showcase Pitch.
10th July 2025 Santander UK, and ABVenture's Microfinance fund- granted
24th July 2025 - Round table conference with the Scottish Minister for Business and Employment, Mr Richard Lochhead in University of Aberdeen.
03rd Sept 2025-CAnswer BioSolutions Ltd. joins Barclays Eagle Labs Funding Readiness programme, powered by Capital Enterprise.
2 October 2025, Edinburgh — Converge file photograph: Dr. Soham Mitra (second from left) receiving the Converge KickStart Runner-Up Trophy from Kate Forbes MSP, Deputy First Minister of Scotland, alongside Adam Kosterka, Executive Director of Converge, and Ann Lewendon, Dean of the University of Aberdeen Business School (from left to right).
“01 Nov 2025, CAnswer BioSolutions Limited is in Venture Builder Incubator 6.O (VBI 6.0), Edinburgh University, as one of the top 6 UK-based teams from Cancer Research Horizon's Oncology Cohort."
“07 Nov 2025, London, From left: Aryan Batheja, Sameer Gouda, Dr. Liliyana Kalinova, and Dr. Soham Mitra with Rob Bell — Receiving Royal Academy of Engineering and E-Careers’ Best Technical Idea Award, at the ESBF Champions of Champion 2025.”
Interested in learning more about our portable punch biopsy kit and AI diagnostic platform? Contact our team for more information or to discuss potential collaborations.
Aberdeen, Scotland, UK
info@canswer-biosolutions.com
Learn more about how our portable punch biopsy kit can transform cancer diagnostics at your facility.
Request Information
